Drug record
What four public record sets show for semaglutide. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | Brand prices only, see table | Details |
| Medicare Part D, 2024 | $15.16 billion | Details |
| FDA recall records | 57 | Details |
Whether the FDA lists this drug as in short supply.
3 products being discontinued. A maker has told the FDA it will stop making these. That is one maker leaving, not a shortage of the drug:
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| OZEMPIC 0.25-0.5 MG/DOSE (2 MG/3 ML) PEN | Brand | $332.02 per mL | — | Oct 21, 2026 |
| OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN | Brand | $331.94 per mL | — | Oct 21, 2026 |
| OZEMPIC 1.5 MG TABLET | Brand | $33.15 per each | $994.59 | Oct 21, 2026 |
| OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN | Brand | $332.00 per mL | — | Oct 21, 2026 |
| OZEMPIC 4 MG TABLET | Brand | $33.19 per each | $995.67 | Oct 21, 2026 |
| OZEMPIC 9 MG TABLET | Brand | $33.19 per each | $995.68 | Oct 21, 2026 |
| RYBELSUS 14 MG TABLET | Brand | $33.19 per each | $995.67 | Oct 21, 2026 |
| RYBELSUS 3 MG TABLET | Brand | $33.19 per each | $995.70 | Oct 21, 2026 |
| RYBELSUS 7 MG TABLET | Brand | $33.19 per each | $995.84 | Oct 21, 2026 |
| WEGOVY 0.25 MG/0.5 ML PEN | Brand | $653.33 per mL | — | Oct 21, 2026 |
| WEGOVY 0.5 MG/0.5 ML PEN | Brand | $653.30 per mL | — | Oct 21, 2026 |
| WEGOVY 1 MG/0.5 ML PEN | Brand | $653.07 per mL | — | Oct 21, 2026 |
| WEGOVY 1.5 MG TABLET | Brand | $43.53 per each | $1,305.81 | Oct 21, 2026 |
| WEGOVY 1.7 MG/0.75 ML PEN | Brand | $435.57 per mL | — | Oct 21, 2026 |
| WEGOVY 2.4 MG/0.75 ML PEN | Brand | $435.57 per mL | — | Oct 21, 2026 |
| WEGOVY 25 MG TABLET | Brand | $43.46 per each | $1,303.89 | Oct 21, 2026 |
| WEGOVY 4 MG TABLET | Brand | $43.49 per each | $1,304.79 | Oct 21, 2026 |
| WEGOVY 9 MG TABLET | Brand | $43.48 per each | $1,304.53 | Oct 21, 2026 |
| WEGOVY HD 7.2 MG/0.75 ML PEN | Brand | $434.94 per mL | — | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $15.16 billion for the 3 products below. That is up 891% from $1.53 billion in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Ozempic Semaglutide | $12.97 billion | 1,952,637 | $1,245.09 | $6,642.45 | $1.46 billion |
| Rybelsus Semaglutide | $1.89 billion | 309,993 | $1,509.97 | $6,097.18 | $73.4 million |
| Wegovy Semaglutide | $301.3 million | 52,961 | $1,424.00 | $5,688.78 | — |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 57 recall records that name semaglutide in the product description (57 Class II). 50 are still marked ongoing.
SEMAGLUTIDE/CYANOCOBALAMIN 9/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936
Reason: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
SEMAGLUTIDE/CYANOCOBALAMIN 3/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936
Reason: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
SEMAGLUTIDE 3 MG/ML INJECTABLE, 8 x 0.1 mL syringes, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936
Reason: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-721-01
Reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05
Reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-811-02
Reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-711-02
Reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-821-01
Reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-810-01
Reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-724-04.
Reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
SEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-722-02
Reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-822-02
Reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for semaglutide. This page is public-record information, not medical advice.